BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33832410)

  • 41. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
    McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Threshold of Toxicological Concern (TTC) is a pragmatic tool for the safety assessment: Case studies of cosmetic ingredients with low consumer exposure.
    Bury D; Head J; Keller D; Klaric M; Rose J;
    Regul Toxicol Pharmacol; 2021 Jul; 123():104964. PubMed ID: 34023455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety Assessment of
    Becker LC; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B
    Int J Toxicol; 2019; 38(3_suppl):48S-70S. PubMed ID: 31840549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety Assessment of Anthemis nobilis-Derived Ingredients as Used in Cosmetics.
    Johnson W; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2017; 36(1_suppl):57S-66S. PubMed ID: 28553737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Final report of the safety assessment of niacinamide and niacin.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2005; 24 Suppl 5():1-31. PubMed ID: 16596767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternative in vitro models used in the main safety tests of cosmetic products and new challenges.
    Filaire E; Nachat-Kappes R; Laporte C; Harmand MF; Simon M; Poinsot C
    Int J Cosmet Sci; 2022 Dec; 44(6):604-613. PubMed ID: 35842748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro testing strategy for assessing the skin sensitizing potential of "difficult to test" cosmetic ingredients.
    Bergal M; Puginier M; Gerbeix C; Groux H; Roso A; Cottrez F; Milius A
    Toxicol In Vitro; 2020 Jun; 65():104781. PubMed ID: 32001296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opinion of the Scientific Committee on Consumer Safety (SCCS) - Revision of the Opinion on hydroxyapatite (nano) in cosmetic products.
    ; Bernauer U
    Regul Toxicol Pharmacol; 2018 Oct; 98():274-275. PubMed ID: 30125613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety Assessment of Silk Protein Ingredients as Used in Cosmetics.
    Johnson W; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B
    Int J Toxicol; 2020; 39(3_suppl):127S-144S. PubMed ID: 33203267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety assessment of alkyl benzoates as used in cosmetics.
    'Becker LC; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler D; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2012; 31(6 Suppl):342S-72S. PubMed ID: 23283706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety Assessment of Fatty Acid Amidopropyl Dimethylamines as Used in Cosmetics.
    Burnett CL; Boyer I; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B
    Int J Toxicol; 2019; 38(1_suppl):39S-69S. PubMed ID: 31170841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Final report of the amended safety assessment of Glyceryl Laurate, Glyceryl Laurate SE, Glyceryl Laurate/Oleate, Glyceryl Adipate, Glyceryl Alginate, Glyceryl Arachidate, Glyceryl Arachidonate, Glyceryl Behenate, Glyceryl Caprate, Glyceryl Caprylate, Glyceryl Caprylate/Caprate, Glyceryl Citrate/Lactate/Linoleate/Oleate, Glyceryl Cocoate, Glyceryl Collagenate, Glyceryl Erucate, Glyceryl Hydrogenated Rosinate, Glyceryl Hydrogenated Soyate, Glyceryl Hydroxystearate, Glyceryl Isopalmitate, Glyceryl Isostearate, Glyceryl Isostearate/Myristate, Glyceryl Isostearates, Glyceryl Lanolate, Glyceryl Linoleate, Glyceryl Linolenate, Glyceryl Montanate, Glyceryl Myristate, Glyceryl Isotridecanoate/Stearate/Adipate, Glyceryl Oleate SE, Glyceryl Oleate/Elaidate, Glyceryl Palmitate, Glyceryl Palmitate/Stearate, Glyceryl Palmitoleate, Glyceryl Pentadecanoate, Glyceryl Polyacrylate, Glyceryl Rosinate, Glyceryl Sesquioleate, Glyceryl/Sorbitol Oleate/Hydroxystearate, Glyceryl Stearate/Acetate, Glyceryl Stearate/Maleate, Glyceryl Tallowate, Glyceryl Thiopropionate, and Glyceryl Undecylenate.
    Int J Toxicol; 2004; 23 Suppl 2():55-94. PubMed ID: 15513825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of QSAR models using artificial neural network analysis for risk assessment of repeated-dose, reproductive, and developmental toxicities of cosmetic ingredients.
    Hisaki T; Aiba Née Kaneko M; Yamaguchi M; Sasa H; Kouzuki H
    J Toxicol Sci; 2015 Apr; 40(2):163-80. PubMed ID: 25786522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety evaluations under the proposed US Safe Cosmetics and Personal Care Products Act of 2013: animal use and cost estimates.
    Knight J; Rovida C
    ALTEX; 2014; 31(2):177-208. PubMed ID: 24468774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety assessment of 2-amino-4-hydroxyethylaminoanisole and 2-amino-4-hydroxyethylaminoanisole sulfate as used in cosmetics.
    Burnett CL; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler D; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2013; 32(3 Suppl):25S-35S. PubMed ID: 23696576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety Assessment of Dimethiconol and Its Esters and Reaction Products as Used in Cosmetics.
    Johnson W; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2017; 36(3_suppl):31S-50S. PubMed ID: 29243542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety assessment of a novel active ingredient, acetyl aspartic acid, according to the EU Cosmetics Regulation and the Scientific Committee on Consumer Safety guidelines.
    Daly P; Moran G
    Int J Cosmet Sci; 2015 Oct; 37 Suppl 1():21-7. PubMed ID: 26114401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of ingredients used in cosmetics.
    Bergfeld WF; Belsito DV; Marks JG; Andersen FA
    J Am Acad Dermatol; 2005 Jan; 52(1):125-32. PubMed ID: 15627090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.